Thymosin Alpha-1 (TA-1).
An immune-regulating peptide for balanced T-cell function and resilience.
Pricing is shown after your free assessment, before you commit.
Free to start. No card required.
Reviewed by Lumora clinical team (Licensed provider network)Mixed evidenceSource: Client-approved product catalog; provider review required
Evidence, regulatory status, and fit vary by medication, formulation, route, and individual history.
Is this for you?
This is for you if
- Patients who get sick frequently or feel immunocompromised
- Patients with chronic inflammation or immune dysregulation
- Patients recovering from illness, stress, or burnout
- Patients wanting immune support during high physical or emotional stress
- Patients pursuing longevity or wellness optimization
This isn't for you if
Generally well tolerated. Patients with active autoimmune disease or on immunosuppressive therapy require specialist clearance.
Thymosin Alpha-1 (TA-1)
Thymosin Alpha-1 (TA-1) is a peptide that supports immune system regulation by improving T-cell function and immune signaling. Rather than overstimulating immunity, it helps normalize immune response — making it useful for both immune weakness and immune imbalance.
Mechanism and fit.
TA-1 enhances immune communication accuracy, supports T-cell function and surveillance, and reduces inappropriate inflammatory signaling. It is one of the most clinically established immune-modulating peptides in physician practice.
Who this is typically for.
- Patients who get sick frequently or feel immunocompromised
- Patients with chronic inflammation or immune dysregulation
- Patients recovering from illness, stress, or burnout
- Patients wanting immune support during high physical or emotional stress
- Patients pursuing longevity or wellness optimization
What patients
most often ask.
Will TA-1 worsen autoimmunity?
TA-1 regulates rather than over-stimulates the immune system, but patients with active autoimmune disease should be evaluated by a specialist before starting.
Who this is typically for.
These are common fit patterns from the approved catalog. Your provider determines whether treatment is appropriate.
- <ul><li>Patients who get sick frequently or feel immunocompromised</li><li>Patients with chronic inflammation or immune dysregulation</li><li>Patients recovering from illness, stress, or burnout</li><li>Patients wanting immune support during high physical or emotional stress</li><li>Patients pursuing longevity or wellness optimization</li></ul>
How this option
is evaluated.
The plan is provider-determined after reviewing your assessment and safety factors.
- Dosing2–3 times per week, provider-directed.
- Typical duration4–8 weeks; may be repeated seasonally or during immune stress.
- Safety and eligibilityYour provider reviews contraindications, medication interactions, goals, and safety factors before prescribing.
- A licensed provider reviews your assessment before any treatment is recommended.
- You see full pricing - visit fees, medication, labs, follow-up - before you commit.
- Your plan can be adjusted, paused, or stopped based on response and safety. Your clinician is reachable - not a chatbot.
- Compounded medications are not FDA-approved and are dispensed only when prescribed by a licensed provider.
Start with
provider review.
If you are considering Thymosin Alpha-1 (TA-1), the first step is a free assessment. A provider determines whether it fits your goals and medical history.
A provider determines whether treatment is clinically appropriate.